National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

10.3 Major clinical issues with somatoform disorders and cannabis/ hallucinogen use

prev pageTOC |next page

Table of contents

10.3.1 Effects of cannabis and other hallucinogens on somatoform disorders

10.3.2 Interactions between cannabis and therapeutic agents for somatoform disorders

10.3.3 Management approaches for comorbid somatoform disorders and cannabis and other hallucinogen use


prev pageTOC |next page